Cancer Genetics
Volume 204, Issue 12 , Pages 654-665 , December 2011

Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia

  • Linsheng Zhang

      Affiliations

    • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA
    • Both authors contributed equally to this work and both are considered first author.
    • ,
  • Iya Znoyko

      Affiliations

    • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA
    • Both authors contributed equally to this work and both are considered first author.
    • ,
  • Luciano J. Costa

      Affiliations

    • Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
    • ,
  • Laura K. Conlin

      Affiliations

    • Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • Robert D. Daber

      Affiliations

    • Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • Sally E. Self

      Affiliations

    • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA
    • ,
  • Daynna J. Wolff

      Affiliations

    • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA
    • Corresponding Author InformationCorresponding author.

Received 13 May 2011 ,Revised 25 October 2011 ,Accepted 28 October 2011.

References 

  1. Grubor V, Krasnitz A, Troge JE, et al. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Blood. 2009;113:1294–1303
  2. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219–234
  3. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206
  4. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–1847
  5. Krober A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410–1416
  6. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351:893–901
  7. Fegan C, Robinson H, Thompson P, et al. Karyotypic evolution in CLL: identification of a new subgroup of patients with deletions of 11q and advanced or progressive disease. Leukemia. 1995;9:2003–2008
  8. Cuneo A, Bigoni R, Rigolin GM, et al. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica. 2002;87:44–51
  9. Finn WG, Kay NE, Kroft SH, et al. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients. Am J Hematol. 1998;59:223–229
  10. Stilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica. 2007;92:1242–1245
  11. Berkova A, Zemanova Z, Trneny M, et al. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma. 2009;56:455–458
  12. Chena C, Avalos JS, Bezares RF, et al. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies. Eur J Haematol. 2008;81:94–99
  13. Stilgenbauer S, Bullinger L, Lichter P, et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia. 2002;16:993–1007
  14. Gahrton G, Robert KH, Friberg K, et al. Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood. 1980;56:640–647
  15. Juliusson G, Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genet Cytogenet. 1990;45:143–160
  16. Nowell PC, Moreau L, Growney P, et al. Karyotypic stability in chronic B-cell leukemia. Cancer Genet Cytogenet. 1988;33:155–160
  17. Dohner H, Stilgenbauer S, Fischer K, et al. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia. 1997;11:S19–S24
  18. Lehmann S, Ogawa S, Raynaud SD, et al. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Cancer. 2008;112:1296–1305
  19. Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci U S A. 2004;101:1039–1044
  20. Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood. 2007;109:1202–1210
  21. Gunn SR, Mohammed MS, Gorre ME, et al. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. J Mol Diagn. 2008;10:442–451
  22. Sargent R, Jones D, Abruzzo LV, et al. Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia. J Mol Diagn. 2009;11:25–34
  23. Hagenkord JM, Monzon FA, Kash SF, et al. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. J Mol Diagn. 2010;12:184–196
  24. Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res. 2009;19:1682–1690
  25. Nancarrow DJ, Handoko HY, Stark MS, et al. SiDCoN: a tool to aid scoring of DNA copy number changes in SNP chip data. PLoS One. 2007;2:e1093
  26. Conlin LK, Thiel BD, Bonnemann CG, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet. 2010;19:1263–1275
  27. Cavazzini F, Cuneo A, de Angeli C, et al. Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11.32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia. Leuk Lymphoma. 2004;45:1197–1203
  28. Gunn SR, Bolla AR, Barron LL, et al. Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Leuk Res. 2009;33:1276–1281
  29. Ouillette P, Collins R, Shakhan S, et al. The prognositc significance of various 13q14 deletions in chronic lymphocytic leukemia. Clinical Cancer Res. 2011;17:6778–6790
  30. Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol. 2006;24:4634–4641
  31. Chevallier P, Penther D, Avet-Loiseau H, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol. 2002;116:142–150
  32. Cross J, Peters G, Wu Z, Brohede J, et al. Resolution of trisomic mosaicism in prenatal diagnosis: estimated performance of a 50K SNP microarray. Prenat Diagn. 2007;27:1197–1204
  33. Ballif BC, Rorem EA, Sundin K, et al. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A. 2006;140A:2757–2767
  34. Xiang B, Li A, Valentin D, Nowak NJ, et al. Analytical and clinical validity of whole-genome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay. Am J Med Genet A. 2008;146A:1942–1954
  35. Greaves M. Darwin and evolutionary tales in leukemia. The Ham-Wasserman Lecture. Hematology Am Soc Hematol Educ Program. 2009;3–12
  36. Gerlinger M, Swanton C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer. 2010;103:1139–1143
  37. Merlo LM, Pepper JW, Reid BJ, et al. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006;6:924–935
  38. Magurran AE. Biological diversity. Curr Biol. 2005;15:R116–R118
  39. Maley CC, Galipeau PC, Finley JC, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet. 2006;38:468–473

PII: S2210-7762(11)00305-X

doi: 10.1016/j.cancergen.2011.10.012

Cancer Genetics
Volume 204, Issue 12 , Pages 654-665 , December 2011

Article Tools

* Image Usage & Resolution